Usefulness of FDG PET in Primary Bone Tumors~!2009-05-15~!2009-12-18~!2010-03-25~!
The Open Bone Journal · 2010
DOI: 10.2174/1876525401002010019 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Bone Journal, 2010. Verfasst von Takashi Yanagawa und 3 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Positron emission tomography (PET) using [ 18 F]fluorodeoxyglucose (FDG) is a useful modality to examine many kinds of tumors, including primary bone tumors.Malignant bone tumors show higher FDG accumulation than benign tumors and earlier reports mention that FDG-PET can differentiate malignancy from benignancy; however, some benign bone tumors present with high FDG accumulation, which increases false positive rates in FDG-PET.FDG accumulation reflects glucose metabolism and thereby FDG-PET can be used for staging malignant bone tumors, which require a large amount of glucose.Combined with conventional studies, such as magnetic resonance imaging (MRI) and scintigraphy, FDG-PET can more accurately decide the staging.Finally, FDG-PET is also applied to evaluate the chemotherapy response of malignant bone tumors and is expected to predict a patient's prognosis and to help to decide appropriate chemotherapy agents.
Zitieren
APA
Yanagawa, T., Watanabe, H., Shinozaki, T., & Takagishi, K. (2010). Usefulness of FDG PET in Primary Bone Tumors~!2009-05-15~!2009-12-18~!2010-03-25~!. The Open Bone Journal. https://doi.org/10.2174/1876525401002010019
Vancouver
Yanagawa T, Watanabe H, Shinozaki T, Takagishi K. Usefulness of FDG PET in Primary Bone Tumors~!2009-05-15~!2009-12-18~!2010-03-25~!. The Open Bone Journal. 2010. doi:10.2174/1876525401002010019
BibTeX
@article{Yanagawa2010,
author = {Yanagawa, Takashi and Watanabe, Hideomi and Shinozaki, Tetsuya and Takagishi, Kenji},
title = {Usefulness of FDG PET in Primary Bone Tumors~!2009-05-15~!2009-12-18~!2010-03-25~!},
journal = {The Open Bone Journal},
year = {2010},
doi = {10.2174/1876525401002010019}
}
EUVIMED